Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gynecologic Oncology

• Publication date

  1999-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/GYNO.1999.5446PMID 10419732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of CSF-1 in normal and neoplastic breast physiology.

  1999cited by this paper
• The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

  1995cited by this paper
• Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer

  1995cited by this paper
• Endometrial carcinoma in breast cancer patients treated with tamoxifen. Two case report and review of the literature.

  1994cited by this paper
• Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

  1994cited by this paper
• Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.

  1994cited by this paper
• Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

  1994cited by this paper
• The proto‐oncogene c‐fms is overexpressed in endometrial cancer

  1994cited by this paper
• Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen.

  1994cited by this paper
• Pathology of endometrium treated with tamoxifen.

  1994cited by this paper
• Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.

  1994cited by this paper
• Is colony‐stimulating factor‐1 a key mediator of breast cancer invasion and metastasis?

  1993cited by this paper
• The proto-oncogene c-fms is overexpressed in endometrial cancer.

  1993cited by this paper
• Principles and Practice of Gynecologic Oncology

  1992cited by this paper
• Expression of colony-stimulating factor-1 in the human uterus and placenta.

  1992cited by this paper
• p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

  1992cited by this paper
• The predominant form of secreted colony stimulating factor-1 is a proteoglycan.

  1992cited by this paper
• Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta.

  1992cited by this paper
• Colony stimulating factor-1 (CSF-1) in pregnancy

  1992cited by this paper
• The biological effects of macrophage‐colony‐stimulating factor induced by progestin on growth and differentiation of endometrial adenocarcinoma cells

  1991cited by this paper
• Expression of the macrophage colony‐stimulating factor and its receptor in gynecologic malignancies

  1991cited by this paper
• Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy.

  1991cited by this paper
• FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro.

  1991cited by this paper
• Colony-stimulating factor-1 receptor.

  1990cited by this paper
• The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients.

  1990cited by this paper
• Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.

  1990cited by this paper
• Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development.

  1989cited by this paper
• Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms.

  1989cited by this paper
• High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas.

  1988cited by this paper
• Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.

  1987cited by this paper
• Apparent role of the macrophage growth factor, CSF-1, in placental development

  1987cited by this paper
• Estrogen and Progesterone Receptors in Uterine Sarcomas

  1986cited by this paper
• CSF‐1—A mononuclear phagocyte lineage‐specific hemopoietic growth factor

  1983cited by this paper
• Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1).

  1981cited by this paper

• Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer

  2021cites this paper
• Endometrial Carcinoma: Specific Targeted Pathways.

  2017cites this paper
• Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

  2006cites this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma.

  2005cites this paper